C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2006
11/30/2006	US20060270681 Pyridazine derivatives
11/30/2006	US20060270676 Hydrazono-malonitriles
11/30/2006	US20060270674 Pharmaceutical composition promoting defecation
11/30/2006	US20060270673 Inhibitors of akt activity
11/30/2006	US20060270672 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
11/30/2006	US20060270670 Methods of synthesizing 6-alkylaminoquinoline derivatives
11/30/2006	US20060270669 Method of preparing 3-cyano-quinolines and intermediates made thereby
11/30/2006	US20060270668 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
11/30/2006	US20060270666 Quinoxaline derivatives as neutrophil elastase inhibitors and their use
11/30/2006	US20060270660 Processes for preparing substituted pyrimidines
11/30/2006	US20060270657 N-substituted heterocyclic sulfonamides
11/30/2006	US20060270652 Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
11/30/2006	US20060270651 Antibacterial agents
11/30/2006	US20060270649 Azetidine derivatives, their preparation and medicaments containing them
11/30/2006	US20060270628 Antiinfective 1,2,3-triazole derivatives, process for their preparation and pharmaceutical compositions containing them
11/30/2006	US20060270613 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylcarbamoyl}phenoxy)benzoic acid, for example; antilipemic agents; anticholesterol agents
11/30/2006	DE102005023858A1 Preparation of spiro-orthoester comprises reaction of a lactone with an epoxide in the presence of a catalyst e.g. heterogeneous acid catalyst
11/30/2006	CA2609980A1 Treatment of protein folding disorders
11/30/2006	CA2609394A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006	CA2609392A1 Modulators of atp-binding cassette transporters
11/30/2006	CA2609235A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
11/30/2006	CA2609203A1 Proline bis-amide orexin receptor antagonists
11/30/2006	CA2608634A1 N-formyl hydroxylamine compounds as pdf inhibitors
11/30/2006	CA2608589A1 Methods of synthesizing 6-alkylaminoquinoline derivatives
11/29/2006	EP1726585A1 Diaryl-substituted five-membered heterocycle derivative
11/29/2006	EP1726306A1 Fasudil-containing preparation and method of improving stability thereof
11/29/2006	EP1725564A1 M3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725546A1 Pyrazolyl indolyl derivatives as ppar activators
11/29/2006	EP1725545A1 Composition comprising an optically-active monomeric compound, method implementing said composition, monomeric compound, polymer comprising same, and use thereof
11/29/2006	EP1725544A1 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
11/29/2006	EP1725543A1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/29/2006	EP1725540A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
11/29/2006	EP1725538A1 Pyridazinone ureas as antagonists of a4 integrins
11/29/2006	EP1725528A2 Sulphonylpyrroles as hdac inhibitors
11/29/2006	EP1725526A2 Method for preparing pyrrolidine oximes
11/29/2006	EP1725525A1 Diphenylmethyl compounds useful as muscarinic receptor antagonists
11/29/2006	EP1725240A1 Muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725239A1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
11/29/2006	EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725232A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
11/29/2006	EP1725103A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
11/29/2006	EP1496051B1 Method for preparing 6-aminomethyl-6,11-dihydro-5h-dibenz(b,e)azepine
11/29/2006	EP1114028B1 Aza-bicycles which modulate the inhibition of cell adhesion
11/29/2006	CN1871236A Novel tetraydrospiro(piperdine-2,7'- pyrrolo{3,2-b}pyridine derivatives and novel in-dole derivatives useful in the treatment of 5-ht6 receptor-related disorders
11/29/2006	CN1871232A Benzimidazolyl derivatives
11/29/2006	CN1871009A 5-arylpyrimidines as anticancer agents
11/29/2006	CN1870991A Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
11/29/2006	CN1869034A An arylether kind compound and its preparation and application
11/29/2006	CN1286836C Novel diketopyrrolopyrrole pigments
11/29/2006	CN1286832C Processes for producing indole compound
11/29/2006	CN1286822C Pyrimidinone compounds
11/29/2006	CN1286810C 2-acyl indol derivatives and their use as anti-tumour agents
11/29/2006	CN1286764C Non-heating clay composites for building materials
11/28/2006	US7141680 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide)
11/28/2006	US7141600 Small molecule inhibition of a PDZ-domain interaction
11/28/2006	US7141587 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/28/2006	US7141585 Pyrazole derivatives
11/28/2006	US7141584 2-(substituted-phenyl)amino-imidazoline derivatives
11/28/2006	US7141581 Modulates and/or inhibits tyrosine kinase signal transduction; antiproliferative agents; treating, prevention of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141574 Viral polymerase inhibitors
11/28/2006	US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
11/28/2006	US7141568 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/28/2006	US7141561 Substituted diaryl heterocycles, process for their preparation and their use as medicaments
11/28/2006	CA2378007C Benzimidazole compounds
11/28/2006	CA2228044C Dibenzimidazole radioprotectors
11/28/2006	CA2164633C Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
11/28/2006	CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006	WO2006124780A2 Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
11/23/2006	WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006	WO2006123242A1 1, 2, 4 -triazole derivatives as vasopressin antagonists
11/23/2006	WO2006123121A1 Histone deacetylase inhibitors
11/23/2006	WO2006122631A1 2-amino-4-phenylquinazoline derivates and their use as hsp90 modulators
11/23/2006	WO2006122408A1 Bir domain binding compounds
11/23/2006	WO2006110884A3 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
11/23/2006	WO2006071538A3 Substituted biaryl analogues
11/23/2006	WO2006069155A3 Inhibitors of protein arginine methyl transferases
11/23/2006	WO2006044732A3 2, 6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
11/23/2006	WO2006029154A3 Novel compounds
11/23/2006	WO2005112932A3 Raf modulators and methods of use
11/23/2006	US20060264644 acidification
11/23/2006	US20060264638 Useful in the treatment of chronic and acute pain; 1-[4-dibenzocycloheptyl-4-piperidinyl]-1,3-dihydro-2H-1,3-benzamidazol-2-one;
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264627 Heterocyclic hydrazones as novel anti-cancer agents
11/23/2006	US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE
11/23/2006	US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006	US20060264496 Substituted indoline and indole derivatives
11/23/2006	US20060264491 Telmisartan production process
11/23/2006	US20060264486 (5-{3-[4-(4,5,6,7-tetrahydro-benzooxazol-2-yl)-phenoxy]-propoxy}-indol-1-yl)-acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic disease
11/23/2006	US20060264477 Methods of using cyclic amides
11/23/2006	US20060264476 Substituted imidazoles and thiazoles; 4-(((6-chloro-2-(3-chlorophenyl)-3-pyridinyl)methoxy)(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile, antitumor agents
11/23/2006	US20060264475 Compounds, compositions and methods for inhibiting or treating hiv-1
11/23/2006	US20060264474 novel sulphonamide, sulphamate and sulphamide derivatives, comprising a m-disubstituted benzene or pyridine ring and a substituted pyrazole moiety, which inhibit the processing of APP by gamma -secretase, and hence are useful in the treatment or prevention of Alzheimer's disease
11/23/2006	US20060264473 3-(4-Benzyloxy-3-methoxy-phenyl)-3-methoxy-2-(2-pyridin-2-yl-ethyl)-2,3-dihydro-isoindol-1-one; viricides; anticarcinogenic agents
11/23/2006	US20060264462 Imidazolamino compounds
11/23/2006	US20060264461 Imidazolamino compounds
11/23/2006	US20060264449 Compounds for modulation of kinesins as anticancer agents with administering
11/23/2006	US20060264444 3-(4-Chlorophenoxy)-5-fluoro-2-methyl-1H-indole-1-acetic acid; asthma and chronic obstructive pulmonary disease (COPD)
11/23/2006	US20060264435 Novel compounds
11/23/2006	US20060264433 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

1 ... 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 ... 626